113882-48-7Relevant articles and documents
Visible-Light Photoredox-Catalyzed α-Allylation of α-Bromocarbonyl Compounds Using Allyltrimethylsilane
Gontala, Arjun,Jang, Gwang Seok,Woo, Sang Kook
, p. 506 - 509 (2021)
The development of a greener allylation reagent for α-allylation of carbonyl compounds is of great necessity. Here we present allyltrimethylsilane as a novel allylation reagent in the photoredox-catalyzed α-allylation of carbonyl compounds such as ketones, esters, and amides. The reaction process shows good functional group tolerance and generates a good yield of the product. The reaction mechanism is a radical-mediated reaction by photo-induced single electron transfer.
Triethylborane-induced radical allylation of α-halo carbonyl compounds with allylgallium reagent in aqueous media
Usugi, Shin-ichi,Yorimitsu, Hideki,Oshima, Koichiro
, p. 4535 - 4538 (2001)
An allylgallium reagent is found to be effective for radical allylation of α-iodo or α-bromo carbonyl compounds. Treatment of benzyl bromoacetate with allylgallium, prepared from allylmagnesium chloride and gallium trichloride, in the presence of triethylborane in THF provided benzyl 4-pentenoate in good yield. The addition of water as a cosolvent improved the yields of allylated products. It was revealed that the allylgallium species resists immediate decomposition on exposure to water.
CYCLOSPORINE COMPOSITIONS AND METHODS OF USE
-
Paragraph 0140-0141, (2020/03/15)
Disclosed herein are cyclosporine compounds and methods for use in the treatment or prevention of neutrophil-mediated inflammation, wherein the compounds inhibit the activity of MRP2 and FPR1.
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
-
Paragraph 0618; 0619; 0620, (2014/10/04)
The present invention provides an efficient process for the synthesis of (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H- benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofiiran-3,4-diol and hydrates thereof and methods for treating disorders in which DOTl -mediated protein methylation plays a part, such as cancer and neurological disorders, by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also provides novel crystalline forms of (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)- 5 -(((( 1 r,3 S)-3 -(2-(5 -(tert-butyl)- 1 H-benzo[d] imidazol-2- yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol and hydrates thereof (Form A, Form B, and Form C), characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well as a unique crystalline structure.